United States Biotechnology & Medical Research

Aradigm Corp (ARDMQ)

Track

Ticker: ARDMQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Froehlich Juergen Kurt Chief Medical Officer Officer
Transaction date
Sale
Price
283.02
Quantity 38,252 -38.9%
Value US$4,557,753
Froehlich Juergen Kurt Chief Medical Officer Officer
Transaction date
Sale
Price
210.22
Quantity 73,873 -9.9%
Value US$505,084
Froehlich Juergen Kurt Chief Medical Officer
Transaction date
Planned sale
Price
56.92
Quantity 55,443 +7.1%
Value US$2,468,225
Froehlich Juergen Kurt Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.76
Quantity 423 -0.5%
Value US$2,859
Froehlich Juergen Kurt Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.45
Quantity 333 -0.4%
Value US$1,482
THOMPSON VIRGIL Non-Executive Director
Transaction date
Sale
Price
0.17
Quantity 3,340 -0.3%
Value US$568
First Eagle Investment Management, LLC Large shareholder
Transaction date
Purchase
Price
0.12
Quantity 40,322,580
Value US$5,000,000
First Eagle Investment Management, LLC Large shareholder
Transaction date
Purchase
Price
0.12
Quantity 41,666,667 +57.6%
Value US$5,000,000
First Eagle Value in Biotechnology Master Fund, Ltd. See Footnote below Large shareholder
Transaction date
Purchase
Price
0.19
Quantity 10,625,000 +17.5%
Value US$2,018,750
NOVO NORDISK A S Large shareholder
Transaction date
Sale
Price
0.17
Quantity 401,469 -1.5%
Value US$68,691
NOVO NORDISK A S Large shareholder
Transaction date
Sale
Price
0.17
Quantity 225,000 -0.8%
Value US$38,182
NOVO NORDISK A S Large shareholder
Transaction date
Sale
Price
0.16
Quantity 250,000 -0.9%
Value US$40,750
NOVO NORDISK A S Large shareholder
Transaction date
Sale
Price
0.16
Quantity 256,675 -0.9%
Value US$42,249
NOVO NORDISK A S Large shareholder
Transaction date
Sale
Price
0.17
Quantity 236,406 -0.9%
Value US$39,031
First Eagle Value in Biotechnology Master Fund, Ltd. See Remarks. Large shareholder
Transaction date
Purchase
Price
0.12
Quantity 19,433,408 +52.4%
Value US$2,300,916
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Sale
Price
0.25
Quantity 5,600,000 -83.8%
Value US$1,400,000
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
0.24
Quantity 10,000 +0.2%
Value US$2,400
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
0.24
Quantity 17,000 +0.3%
Value US$4,080
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
0.24
Quantity 25,000 +0.5%
Value US$6,000
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
0.24
Quantity 45,000 +0.8%
Value US$10,602
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Sale
Price
0.35
Quantity 1,000,000 -13.0%
Value US$350,000
GONDA IGOR Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.75
Quantity 15,000 +30.6%
Value US$11,250
BARKER FRANK H Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 5,000 +14.3%
Value US$5,250
BARKER FRANK H Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 15,000 +75.0%
Value US$15,750
BARKER FRANK H Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 20,000 +inf%
Value US$20,900
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 19,550 +0.3%
Value US$28,348
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.41
Quantity 500 +0.0%
Value US$705
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.40
Quantity 15,130 +0.2%
Value US$21,182
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.39
Quantity 500 +0.0%
Value US$695
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.38
Quantity 11,000 +0.1%
Value US$15,180
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.36
Quantity 3,200 +0.0%
Value US$4,352
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.35
Quantity 63,120 +0.8%
Value US$85,212
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.34
Quantity 16,000 +0.2%
Value US$21,440
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.33
Quantity 41,600 +0.6%
Value US$55,328
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.32
Quantity 7,500 +0.1%
Value US$9,900
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.31
Quantity 3,500 +0.0%
Value US$4,585
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.29
Quantity 3,000 +0.0%
Value US$3,870
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.28
Quantity 7,000 +0.1%
Value US$8,960
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.40
Quantity 635,000 +9.3%
Value US$889,000
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.38
Quantity 110,800 +1.6%
Value US$152,904
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.40
Quantity 300,000 +4.7%
Value US$420,000
RA CAPITAL MANAGEMENT, LLC Large shareholder
Transaction date
Purchase
Price
1.40
Quantity 89,010 +1.4%
Value US$124,614
OTULANA BABTUNDE A VP of Clincal Affairs Officer
Transaction date
Purchase
Price
0.95
Quantity 5,000 +165.6%
Value US$4,750
GONDA IGOR Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.95
Quantity 20,000 +67.5%
Value US$19,000
PERRY MARK W Large shareholder
Transaction date
Sale
Price
2.71
Quantity 2,941 -100.0%
Value US$7,970
NEWHALL CHARLES W III Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
KRAMLICH C RICHARD Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
PERRY MARK W Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
NEHRA JOHN M
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
DORMAN NANCY L Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
MCCONNELL THOMAS C Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
BARRIS PETER J Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
KASE RONALD H
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
ALSOP STEWART II Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
MORRIS PETER Large shareholder
Transaction date
Sale
Price
2.35
Quantity 10,247 -100.0%
Value US$24,091
TRAINOR III EUGENE A Large shareholder
Transaction date
Sale
Price
2.08
Quantity 109 -100.0%
Value US$227
TRAINOR III EUGENE A Large shareholder
Transaction date
Sale
Price
2.08
Quantity 109 -100.0%
Value US$227
TRAINOR III EUGENE A Large shareholder
Transaction date
Sale
Price
2.08
Quantity 218 -100.0%
Value US$453
TRAINOR III EUGENE A Large shareholder
Transaction date
Sale
Price
2.08
Quantity 436 -100.0%
Value US$907
PERRY MARK W Large shareholder
Transaction date
Sale
Price
2.10
Quantity 2,000 -40.5%
Value US$4,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-09-20 2018-09-19 S Sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
38,252 -38.9%
283.02
US$4,557,753 		38,252 -38.9% 283.02 US$4,557,753
2018-01-31 2018-01-29 S Sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
73,873 -9.9%
210.22
US$505,084 		73,873 -9.9% 210.22 US$505,084
2017-04-06 2017-04-04 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer
55,443 +7.1%
56.92
US$2,468,225 		55,443 +7.1% 56.92 US$2,468,225
2016-10-05 2016-10-04 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
423 -0.5%
6.76
US$2,859 		423 -0.5% 6.76 US$2,859
2016-06-23 2016-06-21 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
333 -0.4%
4.45
US$1,482 		333 -0.4% 4.45 US$1,482
2013-12-16 2013-12-13 S Sale THOMPSON VIRGIL Non-Executive Director
3,340 -0.3%
0.17
US$568 		3,340 -0.3% 0.17 US$568
2013-08-29 2013-08-27 B Purchase First Eagle Investment Management, LLC Large shareholder
40,322,580
0.12
US$5,000,000 		40,322,580 0.12 US$5,000,000
2012-12-13 2012-12-11 B Purchase First Eagle Investment Management, LLC Large shareholder
41,666,667 +57.6%
0.12
US$5,000,000 		41,666,667 +57.6% 0.12 US$5,000,000
2011-07-11 2011-07-07 B Purchase First Eagle Value in Biotechnology Master Fund, Ltd.

See Footnote below

Large shareholder
10,625,000 +17.5%
0.19
US$2,018,750 		10,625,000 +17.5% 0.19 US$2,018,750
2010-11-09 2010-11-05 S Sale NOVO NORDISK A S Large shareholder
401,469 -1.5%
0.17
US$68,691 		401,469 -1.5% 0.17 US$68,691
2010-11-05 2010-11-04 S Sale NOVO NORDISK A S Large shareholder
225,000 -0.8%
0.17
US$38,182 		225,000 -0.8% 0.17 US$38,182
2010-11-04 2010-11-03 S Sale NOVO NORDISK A S Large shareholder
250,000 -0.9%
0.16
US$40,750 		250,000 -0.9% 0.16 US$40,750
2010-11-03 2010-11-02 S Sale NOVO NORDISK A S Large shareholder
256,675 -0.9%
0.16
US$42,249 		256,675 -0.9% 0.16 US$42,249
2010-11-02 2010-11-01 S Sale NOVO NORDISK A S Large shareholder
236,406 -0.9%
0.17
US$39,031 		236,406 -0.9% 0.17 US$39,031
2010-06-22 2010-06-18 B Purchase First Eagle Value in Biotechnology Master Fund, Ltd.

See Remarks.

Large shareholder
19,433,408 +52.4%
0.12
US$2,300,916 		19,433,408 +52.4% 0.12 US$2,300,916
2008-10-31 2008-10-29 S Sale RA CAPITAL MANAGEMENT, LLC Large shareholder
5,600,000 -83.8%
0.25
US$1,400,000 		5,600,000 -83.8% 0.25 US$1,400,000
2008-10-23 2008-10-21 B Purchase TANG KEVIN C Large shareholder
10,000 +0.2%
0.24
US$2,400 		10,000 +0.2% 0.24 US$2,400
2008-10-22 2008-10-20 B Purchase TANG KEVIN C Large shareholder
17,000 +0.3%
0.24
US$4,080 		17,000 +0.3% 0.24 US$4,080
2008-10-15 2008-10-13 B Purchase TANG KEVIN C Large shareholder
25,000 +0.5%
0.24
US$6,000 		25,000 +0.5% 0.24 US$6,000
2008-10-14 2008-10-10 B Purchase TANG KEVIN C Large shareholder
45,000 +0.8%
0.24
US$10,602 		45,000 +0.8% 0.24 US$10,602
2008-10-08 2008-10-06 S Sale RA CAPITAL MANAGEMENT, LLC Large shareholder
1,000,000 -13.0%
0.35
US$350,000 		1,000,000 -13.0% 0.35 US$350,000
2008-06-06 2008-06-05 B Purchase GONDA IGOR

Chief Executive Officer

Executive Director
15,000 +30.6%
0.75
US$11,250 		15,000 +30.6% 0.75 US$11,250
2008-04-10 2008-04-04 B Purchase BARKER FRANK H Non-Executive Director
5,000 +14.3%
1.05
US$5,250 		5,000 +14.3% 1.05 US$5,250
2008-04-10 2008-04-03 B Purchase BARKER FRANK H Non-Executive Director
15,000 +75.0%
1.05
US$15,750 		15,000 +75.0% 1.05 US$15,750
2008-04-10 2008-04-02 B Purchase BARKER FRANK H Non-Executive Director
20,000 +inf%
1.05
US$20,900 		20,000 +inf% 1.05 US$20,900
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
19,550 +0.3%
1.45
US$28,348 		19,550 +0.3% 1.45 US$28,348
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
500 +0.0%
1.41
US$705 		500 +0.0% 1.41 US$705
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
15,130 +0.2%
1.40
US$21,182 		15,130 +0.2% 1.40 US$21,182
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
500 +0.0%
1.39
US$695 		500 +0.0% 1.39 US$695
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
11,000 +0.1%
1.38
US$15,180 		11,000 +0.1% 1.38 US$15,180
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,200 +0.0%
1.36
US$4,352 		3,200 +0.0% 1.36 US$4,352
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
63,120 +0.8%
1.35
US$85,212 		63,120 +0.8% 1.35 US$85,212
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
16,000 +0.2%
1.34
US$21,440 		16,000 +0.2% 1.34 US$21,440
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
41,600 +0.6%
1.33
US$55,328 		41,600 +0.6% 1.33 US$55,328
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
7,500 +0.1%
1.32
US$9,900 		7,500 +0.1% 1.32 US$9,900
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,500 +0.0%
1.31
US$4,585 		3,500 +0.0% 1.31 US$4,585
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,000 +0.0%
1.29
US$3,870 		3,000 +0.0% 1.29 US$3,870
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
7,000 +0.1%
1.28
US$8,960 		7,000 +0.1% 1.28 US$8,960
2007-11-05 2007-11-01 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
635,000 +9.3%
1.40
US$889,000 		635,000 +9.3% 1.40 US$889,000
2007-09-13 2007-09-13 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
110,800 +1.6%
1.38
US$152,904 		110,800 +1.6% 1.38 US$152,904
2007-09-13 2007-09-11 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
300,000 +4.7%
1.40
US$420,000 		300,000 +4.7% 1.40 US$420,000
2007-03-28 2007-03-01 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
89,010 +1.4%
1.40
US$124,614 		89,010 +1.4% 1.40 US$124,614
2007-01-30 2007-01-25 B Purchase OTULANA BABTUNDE A

VP of Clincal Affairs

Officer
5,000 +165.6%
0.95
US$4,750 		5,000 +165.6% 0.95 US$4,750
2007-01-30 2007-01-25 B Purchase GONDA IGOR

Chief Executive Officer

Executive Director
20,000 +67.5%
0.95
US$19,000 		20,000 +67.5% 0.95 US$19,000
2004-03-08 2004-03-04 S Sale PERRY MARK W Large shareholder
2,941 -100.0%
2.71
US$7,970 		2,941 -100.0% 2.71 US$7,970
2004-02-24 2004-02-20 S Sale NEWHALL CHARLES W III Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale KRAMLICH C RICHARD Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale PERRY MARK W Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale NEHRA JOHN M
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale DORMAN NANCY L Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale MCCONNELL THOMAS C Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale BARRIS PETER J Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale KASE RONALD H
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale ALSOP STEWART II Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale MORRIS PETER Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
109 -100.0%
2.08
US$227 		109 -100.0% 2.08 US$227
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
109 -100.0%
2.08
US$227 		109 -100.0% 2.08 US$227
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
218 -100.0%
2.08
US$453 		218 -100.0% 2.08 US$453
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
436 -100.0%
2.08
US$907 		436 -100.0% 2.08 US$907
2004-01-09 2004-01-07 S Sale PERRY MARK W Large shareholder
2,000 -40.5%
2.10
US$4,200 		2,000 -40.5% 2.10 US$4,200
Explore more

More insider trading research around Aradigm Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America